GSK 3Q Revenues: £5.6 billion (-10%)*   3Q Earnings: £385 (earnings were £1.0 billion in 3Q13)   YTD Revenues: £16.8 billion (-11%)   YTD Earnings: £1.8 billion (earnings were £3.1 billion YTD13)   Comments: Pharmaceutical sales were £3.7 billion (-4%) and vaccine sales were flat at £922 million, with U.S. sales down 10% to £1.3 billion, impacted by continued price and contracting pressures affecting respiratory sales (-17%). Established product sales were down 14% to £724 million in the quarte...